RO 20-1724 Supplier | CAS 29925-17-5 | Focus Biomolecules
Figure 5 | Hesperetin, a Selective Phosphodiesterase 4 Inhibitor, Effectively Suppresses Ovalbumin-Induced Airway Hyperresponsiveness without Influencing Xylazine/Ketamine-Induced Anesthesia
Ro20-1724 | CAS#29925-17-5 | PDE4 Inhibitor | MedKoo
Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In Vitro
Effect of PKA inhibitors on rolipram, Ro-20-1724 and forskolin induced... | Download Scientific Diagram
Concentration responses of RO 20-1724 determined in the PDE4 cell line... | Download Scientific Diagram
Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference | Neuropsychopharmacology
Regulation of 3′,5′-cAMP in Preglomerular Smooth Muscle and Endothelial Cells From Genetically Hypertensive Rats | Hypertension
Ro 20-1724 | ≥99%(HPLC) | Selleck | PDE 阻害剤
Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L‐type Ca2+ current in rat ventricular myocytes - Verde - 1999 - British Journal of Pharmacology - Wiley Online Library
Enzo Life Sciences RO-20-1724, (1g), CAS Number: 29925-17-5, Quantity: | Fisher Scientific
Ro 20-1724, Tocris Bioscience, Quantity: 50mg | Fisher Scientific
Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference | Neuropsychopharmacology
Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. - Abstract - Europe PMC
Ro 20-1724 | CAS:29925-17-5 | PDE4 inhibitor | High Purity | Manufacturer BioCrick
Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, CAS Number: 29925-17-5) | Cayman Chemical
Synergistic Inhibition of Vascular Smooth Muscle Cell Migration by Phosphodiesterase 3 and Phosphodiesterase 4 Inhibitors | Circulation Research
Ro 20-1724 | 29925-17-5 | Buy Ro 20-1724 from Supplier EMMX™
Ro 20-1724 (Ro 20-174) | PDE4/PDE IV Inhibitor | MedChemExpress
![29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...](https://www.trc-canada.com/prod-img/R700903.png "29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...")
29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...
Ro 20-1724 | CAS 29925-17-5 | PDE4 inhibitor
Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle | Journal of Pharmacology and ...
Synergistic Inhibition of Vascular Smooth Muscle Cell Migration by Phosphodiesterase 3 and Phosphodiesterase 4 Inhibitors | Circulation Research
RO 20-1724 Supplier | CAS 29925-17-5 | Focus Biomolecules
